SK pharmteco, a subsidiary of South Korea’s SK Inc., develops and manufactures pharmaceutical therapies as a global contract development and manufacturing organization. Its seven facilities across North America, Europe, and South Korea support small-molecule and peptide programs alongside viral-vector manufacturing, with services extending from process development and analytical testing through commercial production. The company traces its CDMO business to 1996 and entered cell and gene therapy through its 2021 acquisition of French viral-vector specialist Yposkesi.
CGMP
compliance_program
IDT BiologikaFounded in 1921, IDT Biologika is a Dessau-Rosslau-based global CDMO that develops and manufactures vaccines, viral vectors, biologics and sterile injectables from early development through commercial supply. Its particular strength is more than a century of experience working with live viruses, supported by BSL-2 facilities, integrated process development and manufacturing, and in-house quality and analytical services. Now part of SK bioscience, the company employs about 1,600 people and serves pharmaceutical and biotechnology customers as well as governments worldwide.ROCKVILLE, MD
Patheon pharma services (Thermo Fisher Scientific)Patheon Pharma Services is the pharmaceutical services business of Thermo Fisher Scientific, known for more than two decades of viral-vector development and manufacturing experience. It helps biotech and pharmaceutical developers move medicines from early development through clinical trials and commercial production, with specialized work in mRNA and gene-therapy programs.ALLENTOWN, PA
LOTTE BIOLOGICSLOTTE BIOLOGICS is a global CDMO focused on helping pharmaceutical companies develop and manufacture biologic therapies. Its work spans development through clinical and commercial production, supported by GMP facilities in Syracuse, New York, and a planned Songdo Bio Campus in South Korea.EAST SYRACUSE, NY
Ajinomoto Bio-Pharma ServicesWith more than 40 years in small-molecule manufacturing, Ajinomoto Bio-Pharma Services develops and produces pharmaceutical APIs and intermediates for drug companies worldwide. Its CDMO capabilities span the path from preclinical work through commercialization, while on-site analytical laboratories characterize molecules and support quality testing throughout their life cycle. Through Forge Biologics, a member of Ajinomoto Bio-Pharma Services, the company also provides AAV and plasmid manufacturing from preclinical through commercial stages.COLUMBUS, OH